Tissue factor/FVIIa activates Bcl-2 and prevents doxorubicin-induced apoptosis in neuroblastoma cells
<p>Abstract</p> <p>Background</p> <p>Tissue factor (TF) is a transmembrane protein that acts as a receptor for activated coagulation factor VII (FVIIa), initiating the coagulation cascade. Recent studies demonstrate that expression of tumor-derived TF also mediates intr...
Main Authors: | Alvarado Carlos S, Tang Hao, Zhu Ningxi, Gu Lubing, Fang Jun, Zhou Muxiang |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2008-03-01
|
Series: | BMC Cancer |
Online Access: | http://www.biomedcentral.com/1471-2407/8/69 |
Similar Items
-
Adipocytes express tissue factor and FVII and are procoagulant in a TF/FVIIa-dependent manner
by: Desirée Edén, et al.
Published: (2019-07-01) -
Rapid reversal of anticoagulant bleeding- rFVIIa an option?
by: Zupancic-Salek Silva
Published: (2007-01-01) -
Bioengineering of rFVIIa Biopharmaceutical and Structure Characterization for Biosimilarity Assessment
by: Othman Montacir, et al.
Published: (2018-01-01) -
The effect of vorinostat on the development of resistance to doxorubicin in neuroblastoma.
by: Timothy B Lautz, et al.
Published: (2012-01-01) -
Recombinant activated factor VII (rFVIIa) as salvage treatment for intractable hemorrhage
by: Aggarwal Anita, et al.
Published: (2004-11-01)